Results 81 to 90 of about 173,777 (119)

An Orthotopic Xenograft Model for Preclinical Evaluation of CAR T Cell Therapy in Glioblastoma. [PDF]

Curr Protoc
Hübner J, McFleder R, Ip CW, Alb M, Einsele H, Hudecek M, Nerreter T.   +6 more
europepmc   +1 more source

Anti-GBM/ANCA double-positive crescentic nephritis in an elderly patient presenting with heart failure-like symptoms: A case report. [PDF]

Medicine (Baltimore)
Shi M, Shi G, Liu H, Huang Y, Luo N, Ge Y, Zhu J.   +6 more
europepmc   +1 more source

The Circadian Clock in Glioblastoma: Mechanisms and Therapeutic Potential. [PDF]

Clocks Sleep
Ghorbani Shirkouhi S, Kamari F, Høilund-Carlsen PF, Blaabjerg M, Alavi A, Poulsen FR, Revheim MR, Pereira da Silva AM, Andalib S.   +8 more
europepmc   +1 more source

Deepening the Understanding of Platelet-Derived RNA as Biomarker for Glioblastoma Through GSEA, TDEA, and Elastic Net Regularization Analysis. [PDF]

Cancer Rep (Hoboken)
Giczewska A, Pastuszak K, van Hout L, Post E, Ramaker J, Zwaan K, Supernat A, Westerman BA.   +7 more
europepmc   +1 more source

Integrated Genetic Screening Identifies FEN1 as a Selective Vulnerability and Temozolomide Resistance Mediator in Glioblastoma Stem Cells. [PDF]

Cancer Res Commun
Brakel BA, McKenna D, Puri A, Shaikh MV, Singh M, Saleh A, Tomajian AJ, Mikolajewicz N, Beltrami M, Topley M, Anand A, Miletic P, Brown KR, Tieu D, Maich W, Salim S, Suk Y, Subapanditha M, Gendoo DMA, Venugopal C, Moffat J, Katyal S, Chokshi CR, Singh SK.   +23 more
europepmc   +1 more source

Effects of Sodin 5 on the Proliferation and Migration of Human Glioblastoma Cells. [PDF]

Toxins (Basel)
Russo V, Ragucci S, Russo M, Oliva MA, Landi N, Di Maro A, Arcella A.   +6 more
europepmc   +1 more source

Glioblastoma stem cell-immune microenvironment crosstalk: molecular mechanisms and therapeutic opportunities. [PDF]

Front Immunol
Xu C, Chai L, Yuan W.
europepmc   +1 more source

CDK2/9 blockade remodels chromatin and drives phenotypic plasticity in glioblastoma organoids. [PDF]

Cell Commun Signal
Kaps P, Hieltscher AS, Auditore A, Kamper C, Nelz SC, Heskamp J, Meißner P, Wolff A, Richter K, Brandstetter J, Grabarczyk P, Troschke-Meurer S, Hinz B, Wittig F, Dubinski D, Gessler F, Freiman TM, Stählke S, Ficht PK, Boeckmann L, Polley C, Classen CF, Junghanss C, Maletzki C.   +23 more
europepmc   +1 more source

Reduced DDB2 Expression Is Associated with Temozolomide Resistance in Glioblastoma Cells. [PDF]

Int J Mol Sci
Grávalos-Cano I, Morales-Ruiz T, Ariza RR, Roldán-Arjona T, Martínez-Macías MI.   +4 more
europepmc   +1 more source